Inventor · disambiguated record
Elizabeth M. Doherty
Also filed as: DOHERTY ELIZABETH M
24 granted patents·5 pending applications·235 citations·filing 1990–2021
95Inventor score
Top patents by PatentIndex Score
29 records- 0192US5362912AProcess for the preparation of a substituted diaminodiolABBOTT LAB·Filed 1993·Granted Nov 8, 1994·43 cites·10 claims
- 0291US7579347B2Vanilloid receptor ligands and their use in treatmentsAMGEN INC·Filed 2005·Granted Aug 25, 2009·17 cites·9 claims
- 0391US7265138B2Vanilloid receptor ligands and their use in treatmentsAMGEN INC·Filed 2004·Granted Sep 4, 2007·48 cites·12 claims
- 0487US8557830B2RAF kinase modulators and methods of useSMITH ADRIAN L·Filed 2008·Granted Oct 15, 2013·10 cites·13 claims
- 0585US11806346B2HTT modulators for treating Huntington's diseaseCHDI FOUNDATION INC·Filed 2021·Granted Nov 7, 2023·1 cites·37 claims
- 0685US6977264B2Substituted piperidines and methods of useAMGEN INC·Filed 2002·Granted Dec 20, 2005·26 cites·19 claims
- 0784US7053088B2Vanilloid receptor ligands and their use in treatmentsAMGEN INC·Filed 2003·Granted May 30, 2006·19 cites·22 claims
- 0882US7396831B2Vanilloid receptor ligands and their use in treatmentsAMGEN INC·Filed 2005·Granted Jul 8, 2008·5 cites·21 claims
- 0981US5080795ASupported chiral liquid membrane for the separation of enantiomersRES CORP TECHNOLOGIES INC·Filed 1990·Granted Jan 14, 1992·36 cites·39 claims
- 1079US7534798B2Vanilloid receptor ligands and their use in treatmentsAMGEN INC·Filed 2005·Granted May 19, 2009·4 cites·12 claims
- 1177US7144888B2Vanilloid receptor ligands and their use in treatmentsAMGEN INC·Filed 2003·Granted Dec 5, 2006·9 cites·25 claims
- 1273US8440674B2Substituted pyrimidine compounds as RAF inhibitors and methods of useDE MORIN FRENEL F·Filed 2011·Granted May 14, 2013·4 cites·12 claims
- 1372US7148221B2Vanilloid receptor ligands and their use in treatmentsAMGEN INC·Filed 2005·Granted Dec 12, 2006·1 cites·19 claims
- 1471US7582657B2Vanilloid receptor ligands and their use in treatmentsAMGEN INC·Filed 2002·Granted Sep 1, 2009·4 cites·36 claims
- 1569US7511044B2Vanilloid receptor ligands and their use in treatmentsAMGEN INC·Filed 2005·Granted Mar 31, 2009·1 cites·5 claims
- 1664US2009264424A1Vanilloid receptor ligands and their use in treatmentsAMGEN INC·Filed 2009·Application pending·0 cites
- 1763US8716281B2Pyrimidine compounds that inhibit anaplastic lymphoma kinaseBRYAN MARIAN C·Filed 2011·Granted May 6, 2014·1 cites·41 claims
- 1857US2014005198A1Raf kinase modulators and methods of useAMGEN INC·Filed 2013·Application pending·0 cites
- 1954US7524874B2Vanilloid receptor ligands and their use in treatmentsAMGEN INC·Filed 2005·Granted Apr 28, 2009·0 cites·19 claims
- 2054US7332511B2Vanilloid receptor ligands and their use in treatmentsAMGEN INC·Filed 2005·Granted Feb 19, 2008·0 cites·19 claims
- 2154US5235052AProcess for preparing substituted cyclobutane purinesBRISTOL MYERS SQUIBB CO·Filed 1991·Granted Aug 10, 1993·4 cites·3 claims
- 2253US8227469B2Vanilloid receptor ligands and their use in treatmentsBALAN CHENERA·Filed 2009·Granted Jul 24, 2012·0 cites·9 claims
- 2348US5312963AProcess for preparing substituted cyclobutanesBRISTOL MYERS SQUIBB CO·Filed 1993·Granted May 17, 1994·2 cites·4 claims
- 2446US9636418B2Potent and selective inhibitors of NAV1.7AMGEN INC·Filed 2014·Granted May 2, 2017·0 cites·24 claims
- 2544US2006241296A1Vanilloid receptor ligands and their use in treatmentsDOHERTY ELIZABETH M·Filed 2006·Application pending·0 cites
- 2643US10344060B2Potent and selective inhibitors of Nav1.7AMGEN INC·Filed 2014·Granted Jul 9, 2019·0 cites·25 claims
- 2743US2016067347A1Apj receptor agonists and uses thereofAMGEN INC·Filed 2013·Application pending·0 cites
- 2843US2006235036A1Vanilloid receptor ligands and their use in treatmentsDOHERTY ELIZABETH M·Filed 2006·Application pending·0 cites
- 2935US5399775AProcess for preparing substituted cyclobutanesBRISTOL MYERS SQUIBB CO·Filed 1993·Granted Mar 21, 1995·0 cites·1 claims
Join the waitlist — get patent alerts
Get an alert when Elizabeth M. Doherty files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →